Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anterior Capsule of the Lens | 1 | 2019 | 3 | 0.660 |
Why?
|
| Capsulorhexis | 1 | 2019 | 12 | 0.650 |
Why?
|
| Cataract Extraction | 4 | 2022 | 467 | 0.630 |
Why?
|
| Cataract | 3 | 2022 | 832 | 0.440 |
Why?
|
| Phacoemulsification | 2 | 2013 | 149 | 0.400 |
Why?
|
| Laser Therapy | 1 | 2019 | 1092 | 0.390 |
Why?
|
| Exfoliation Syndrome | 1 | 2010 | 113 | 0.320 |
Why?
|
| Macular Edema | 1 | 2010 | 374 | 0.250 |
Why?
|
| Ophthalmology | 2 | 2018 | 550 | 0.180 |
Why?
|
| Diabetic Retinopathy | 1 | 2010 | 1274 | 0.180 |
Why?
|
| Dexmedetomidine | 1 | 2022 | 319 | 0.150 |
Why?
|
| Visual Acuity | 2 | 2019 | 2672 | 0.140 |
Why?
|
| Corneal Diseases | 1 | 2002 | 542 | 0.130 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2021 | 738 | 0.120 |
Why?
|
| Pseudophakia | 1 | 2013 | 60 | 0.110 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 2 | 1999 | 56 | 0.110 |
Why?
|
| Refraction, Ocular | 1 | 2013 | 184 | 0.100 |
Why?
|
| Lens Implantation, Intraocular | 1 | 2013 | 191 | 0.100 |
Why?
|
| Intraoperative Complications | 1 | 2018 | 1165 | 0.100 |
Why?
|
| Retinal Rod Photoreceptor Cells | 2 | 1999 | 204 | 0.090 |
Why?
|
| Program Development | 1 | 2016 | 1297 | 0.090 |
Why?
|
| Genes, Recessive | 2 | 1999 | 623 | 0.090 |
Why?
|
| Lens Capsule, Crystalline | 1 | 2010 | 39 | 0.090 |
Why?
|
| Epithelial Cells | 1 | 2002 | 3673 | 0.090 |
Why?
|
| Triamcinolone Acetonide | 1 | 2010 | 100 | 0.080 |
Why?
|
| Eye Proteins | 2 | 1999 | 633 | 0.080 |
Why?
|
| Retinitis Pigmentosa | 2 | 1999 | 397 | 0.080 |
Why?
|
| Autoimmune Diseases | 1 | 2021 | 2244 | 0.080 |
Why?
|
| Laser Coagulation | 1 | 2010 | 330 | 0.070 |
Why?
|
| Point Mutation | 2 | 1999 | 1595 | 0.070 |
Why?
|
| Eye Foreign Bodies | 1 | 2006 | 52 | 0.060 |
Why?
|
| Disease Management | 1 | 2016 | 2508 | 0.060 |
Why?
|
| Aqueous Humor | 1 | 1996 | 153 | 0.060 |
Why?
|
| Curriculum | 1 | 2018 | 3743 | 0.060 |
Why?
|
| Rec A Recombinases | 1 | 1994 | 50 | 0.060 |
Why?
|
| Metalloendopeptidases | 1 | 1996 | 393 | 0.060 |
Why?
|
| Orbit | 1 | 2006 | 457 | 0.050 |
Why?
|
| Growth Hormone | 1 | 1995 | 569 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2018 | 4792 | 0.050 |
Why?
|
| Protease Inhibitors | 1 | 1996 | 754 | 0.050 |
Why?
|
| Acromegaly | 1 | 1995 | 310 | 0.050 |
Why?
|
| Anterior Eye Segment | 1 | 2002 | 143 | 0.050 |
Why?
|
| Genes, Bacterial | 1 | 1994 | 1073 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2010 | 2161 | 0.040 |
Why?
|
| Eye Injuries, Penetrating | 1 | 2002 | 124 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2010 | 2047 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2002 | 15631 | 0.040 |
Why?
|
| Epithelium, Corneal | 1 | 2002 | 253 | 0.040 |
Why?
|
| Fasting | 1 | 1995 | 1603 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 3492 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2018 | 5880 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 1994 | 1458 | 0.030 |
Why?
|
| Perioperative Care | 1 | 2022 | 1033 | 0.030 |
Why?
|
| Humans | 13 | 2022 | 761504 | 0.030 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 6 | 2 | 1999 | 27 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 9177 | 0.030 |
Why?
|
| Disease Progression | 1 | 2010 | 13506 | 0.030 |
Why?
|
| Gene Frequency | 1 | 1999 | 3606 | 0.030 |
Why?
|
| Lenses, Intraocular | 1 | 2013 | 139 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1995 | 4936 | 0.020 |
Why?
|
| Hospitals, Teaching | 1 | 2013 | 1156 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2013 | 1813 | 0.020 |
Why?
|
| Benchmarking | 1 | 2013 | 1045 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2013 | 64680 | 0.020 |
Why?
|
| Massachusetts | 1 | 2018 | 8830 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2021 | 80636 | 0.020 |
Why?
|
| Pedigree | 2 | 1999 | 4542 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1995 | 386 | 0.010 |
Why?
|
| Prevalence | 1 | 2021 | 15732 | 0.010 |
Why?
|
| Base Sequence | 2 | 1995 | 12441 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1994 | 851 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1995 | 13446 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 1995 | 17635 | 0.010 |
Why?
|
| Genetic Heterogeneity | 1 | 1995 | 732 | 0.010 |
Why?
|
| Mutagenesis, Insertional | 1 | 1994 | 656 | 0.010 |
Why?
|
| Cattle | 1 | 1996 | 3849 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 26125 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 21353 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 1999 | 329 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1994 | 4174 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 1996 | 1349 | 0.010 |
Why?
|
| Eating | 1 | 1995 | 1539 | 0.010 |
Why?
|
| Reference Values | 1 | 1995 | 4920 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 1995 | 4111 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 1995 | 6228 | 0.010 |
Why?
|
| Radiography | 1 | 2006 | 6965 | 0.010 |
Why?
|
| DNA Primers | 1 | 1999 | 2819 | 0.010 |
Why?
|
| Adult | 4 | 2013 | 221177 | 0.010 |
Why?
|
| Exons | 1 | 1999 | 2391 | 0.010 |
Why?
|
| Male | 5 | 2013 | 360804 | 0.010 |
Why?
|
| Middle Aged | 3 | 2013 | 220895 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 58976 | 0.000 |
Why?
|
| Sequence Analysis, DNA | 1 | 1999 | 4740 | 0.000 |
Why?
|
| Female | 4 | 2013 | 392644 | 0.000 |
Why?
|
| Aged | 2 | 2013 | 169289 | 0.000 |
Why?
|
| Cohort Studies | 1 | 1995 | 41487 | 0.000 |
Why?
|
| Child | 1 | 1995 | 80153 | 0.000 |
Why?
|
| Adolescent | 1 | 1995 | 88319 | 0.000 |
Why?
|
| Animals | 1 | 1996 | 168459 | 0.000 |
Why?
|
Concepts
(99)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_